Regenesis

Focus: Regenesis is a biotechnology company specializing in pain-alleviating electromagnetic devices, headquartered in Scottsdale, Arizona with a focus on neurology indications. The company operates at an undisclosed scale with a diversified pipeline of device-based therapies.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About Regenesis

AI assessmentNot Hiring

No open roles listed right now. Follow Regenesis to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

14 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

Provant Therapy System

Pain / Painful Peripheral Diabetic Neuropathy / Osteoarthritis, Knee

Growth

Flagship electromagnetic therapy platform with multiple indication trials spanning acute and chronic pain states.

Provant Infinity Therapy System

Postoperative Pain

Help build intelligence for Regenesis

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Exposure to innovative biomedical device technology in high-demand pain management and neurology markets
Diverse pipeline across 14 clinical programs spanning diabetic neuropathy, post-operative pain, and emerging neuro indications like Parkinson's Disease
Ground-floor opportunity at an early-stage company with multiple therapeutic area expansion potential

Watch Out For

No active job openings currently listed, suggesting minimal near-term hiring or organizational contraction
Complete absence of financial data (revenue, funding, cash position) creates visibility risk and raises questions about financial runway and growth trajectory
All pipeline programs lack defined clinical phases, indicating either early-stage development or data transparency issues that complicate career planning

Generated by Claude from Regenesis's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Next-generation device variant targeting high-prevalence surgical pain indication with commercial potential.

Pulsed Radiofrequency Energy / Pulsed Electromagnetic Field Device

Post-Operative Pain / Total Knee Arthroplasty

Growth

Modality variants expanding addressable market in orthopedic and post-operative settings.

Pipeline & Clinical Trials

Provant Therapy System

Pain

N/A

Active Provant Therapy System

Diabetic Peripheral Neuropathy

N/A

Active Provant Therapy System

Diabetic Neuropathy Peripheral

N/A

Pulsed Radiofrequency Energy

Post-operative Pain

N/A

Pulsed Electromagnetic Field Device

Post-Operative Pain Following Total Knee Arthroplasty

N/A

Provant

Painful Peripheral Diabetic Neuropathy

N/A

Provant Infinity Therapy System

Postoperative Pain

N/A

Provant Therapy System

Painful Peripheral Diabetic Neuropathy

N/A

Transcranial focused ultrasound modulation administered to a region involved in disease pathology.

Parkinson Disease

N/A

Provant Therapy System

Osteoarthritis, Knee

N/A

Distraction Enterogenesis in Adult Patients with Short Bowel Syndrome

Short Bowel Syndrome

N/A

Clinical Trials (1)

NCT05535361A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome

N/A

The Provant Therapy System

Diabetic Foot Ulcers

N/A

Provant Device

Venous Stasis Ulcers

N/A

Provant

Lumbar Surgery

N/A